Truist Financial Raises Omega Healthcare Investors (NYSE:OHI) Price Target to $32.00

Omega Healthcare Investors (NYSE:OHI - Get Free Report) had its price objective increased by analysts at Truist Financial from $31.00 to $32.00 in a report issued on Tuesday, Benzinga reports. The firm presently has a "hold" rating on the real estate investment trust's stock. Truist Financial's price target points to a potential upside of 2.96% from the company's previous close.

Several other research analysts have also recently issued reports on OHI. BNP Paribas raised Omega Healthcare Investors from an "underperform" rating to a "neutral" rating and set a $30.00 target price on the stock in a research report on Thursday, February 8th. Citigroup raised Omega Healthcare Investors from a "neutral" rating to a "buy" rating and lifted their target price for the company from $32.00 to $35.00 in a research report on Friday, March 22nd. Wells Fargo & Company raised Omega Healthcare Investors from an "equal weight" rating to an "overweight" rating and lifted their target price for the company from $31.00 to $35.00 in a research report on Monday, February 26th. Deutsche Bank Aktiengesellschaft initiated coverage on Omega Healthcare Investors in a research report on Tuesday, January 30th. They set a "buy" rating and a $36.00 target price on the stock. Finally, Bank of America cut Omega Healthcare Investors from a "buy" rating to a "neutral" rating and cut their price objective for the stock from $33.00 to $31.00 in a research report on Tuesday, January 16th. Seven equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $33.58.

Omega Healthcare Investors Stock Down 2.3 %

Shares of NYSE OHI traded down $0.74 during midday trading on Tuesday, hitting $31.08. 1,873,518 shares of the stock traded hands, compared to its average volume of 1,867,955. The company has a market cap of $7.62 billion, a PE ratio of 31.39, a P/E/G ratio of 10.43 and a beta of 0.91. Omega Healthcare Investors has a one year low of $26.00 and a one year high of $34.77. The business has a 50 day moving average price of $30.54 and a two-hundred day moving average price of $31.39. The company has a debt-to-equity ratio of 1.35, a quick ratio of 6.76 and a current ratio of 6.76.

Institutional Trading of Omega Healthcare Investors

Several hedge funds have recently made changes to their positions in the company. Left Brain Wealth Management LLC raised its stake in shares of Omega Healthcare Investors by 2.0% in the fourth quarter. Left Brain Wealth Management LLC now owns 17,365 shares of the real estate investment trust's stock valued at $532,000 after buying an additional 335 shares during the period. CreativeOne Wealth LLC raised its stake in shares of Omega Healthcare Investors by 3.9% during the 2nd quarter. CreativeOne Wealth LLC now owns 9,530 shares of the real estate investment trust's stock valued at $292,000 after purchasing an additional 356 shares during the period. Belpointe Asset Management LLC raised its stake in shares of Omega Healthcare Investors by 2.5% during the 1st quarter. Belpointe Asset Management LLC now owns 14,406 shares of the real estate investment trust's stock valued at $395,000 after purchasing an additional 356 shares during the period. BOKF NA raised its stake in shares of Omega Healthcare Investors by 1.1% during the 4th quarter. BOKF NA now owns 35,004 shares of the real estate investment trust's stock valued at $1,073,000 after purchasing an additional 365 shares during the period. Finally, Royal Fund Management LLC raised its stake in shares of Omega Healthcare Investors by 1.0% during the 4th quarter. Royal Fund Management LLC now owns 35,656 shares of the real estate investment trust's stock valued at $1,093,000 after purchasing an additional 369 shares during the period. 65.25% of the stock is currently owned by institutional investors.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.